Home |  Products & Services | Risk Management | Claims | Events | Contact Us | For Participants Only

Our Risk Management department is staffed by experienced professionals with legal and clinical backgrounds.

This combination provides our client with assistance from staff who have a thorough understanding of both the clinical situation and the legal issues and their implications. Our programs and services include:
· Risk Identification
· Risk Reduction
· Loss Prevention
· Risk Management Education

We identify and implement sound risk management services to help you avoid potential incidents and lawsuits.


Let the Risk Managers of The Program keep you up to date with the latest in professional liability news.

NEJM Publishes Article on Meaningful Use by National Coordinator for Health IT David Blumenthal
July 13, 2010: Today the New England Journal of Medicine published an article written by National Coordinator for Health IT David Blumenthal, MD, MPP and Principle Deputy Administrator of CMS Marilyn Tavenner, RN, MHA discussing the final rule governing Meaningful Use for 2011 and 2012. The article includes a summary list of the objectives and corresponding measures for acheiving meaningful use. To read the article, click here.

CMS Publishes New Website About EHRs and Meaningful Use
June 18, 2010: CMS today published a new website with information about Electronic Health Records and the Meaningful Use incentive program. The site includes information about eligibility requirements and certification of records systems, and will be updated with information about registering for the incentives, the definition of meaningful use, and training programs and other events as it becomes available. Visit the site at http://www.cms.gov/EHRIncentivePrograms

FTC Delays Enforcement of Red Flags Rule until December 31, 2010
June 1, 2010: The FTC has again delayed the enforcement of the Reg Flags Rule to December 31, 2010. The AMA has also filed a lawsuit to block application of the Rule to physicians, and Congress has proposed an amendment to the law which would apply the Rule to healthcare practices, but only to those with 20 or more employees.

Despite the recent developments, it would be prudent for physicians to assume that the Rule will be enforced starting 12/31/2010. The AMA has resources related to the Red Flags Rule, including sample forms and policies, available here. To read the FTC press release about the most recent enforcement delay, click here.

FTC Delays Enforcement of Red Flag Rules to June 1, 2010
Oct 30, 2009: The FTC has delayed enforcement of the Red Flag Rules to June 1, 2010, and the AMA continues to advocate against application of the Rules to physicians. However, the safest approach for physicians is to assume that the Rules will be applied to their practices. To read the AMA press release, click here. For guidance documents from the FTC, click here.


AACAP Publishes New Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents

Sept. 2009:The American Academy of Child and Adolescent Psychiatry has published a
new Practice Parameter that discusses suggested best practice principles for managing psychotropic medication in children and adolescents. To read the Practice Parameter,
click here.

CMS Publishes HIPAA FAQ Sheet for Providers
Sept. 2009: CMS has published a Providers' Privacy Guide to address some questions frequently asked by providers about the impact of HIPAA's Privacy Rule. Topics addressed include communicating with other providers, communicating with family members, and reporting child abuse. However, providers should also remember that HIPAA is a floor of privacy protections, and state law may be more restrictive on sharing information. To access the guide, click here.

APA and ACOG Issue Joint Guidelines for the Management of Depression During Pregnancy
Sept. 2009: A joint study conducted by representatives of the APA and ACOG (American College of Obstetricians and Gynecologists) has produced guidelines for managing depression during pregnancy and for patients who are trying to become pregnant. The guidelines discuss evaluation and various treatment options, and provides treatment algorithms to help providers identify the best treatment options. To read the APA press release in Psychiatric News, click here. For the ACOG press release, click here. To read the report, click here.

Joint Commission Issues Sentinel Event Alert About the Importance of Leadership's Role in Patient Safety
Aug 27, 2009: Today the Joint Commission issued a Sentinel Event Alert discussing the importance of an organization's leadership playing an active role in the promotion of patient safety. The Alert provides 14 (fourteen) suggested actions for senior leadership to take to more fully promote and support a culture of safety within their organization. To read the Alert, click here.

FTC Delays Enforcement of Red Flag Rules until November 1, 2009, Issues a Frequently Asked Questions List.
July 29, 2009: The FTC today announced that it has moved the deadline for compliance with the Red Flag Rules back from August 1, 2009 to November 1, 2009. FTC has also published a list of Frequently Asked Questions about interpreting and complying with the regulations. For more information, click here.


CMS (Centers for Medicare and Medicaid Services) Issues a SCAM ALERT NOTICE Warning
June 18, 2009: CMS has issued a SCAM ALERT NOTICE warning of perpetrators posing as Medicare Contractors or Carriers faxing providers a questionnaire to provide account information. The fax may have the CMS logo and/or the contractor logo. CMS advises providers to check with the carrier / contractor before submitting any information. To view the Scam Alert Notice, click here.


FTC Delays Enforcement of Red Flag Rules Until August 1, 2009
Apr 30, 2009:  The Federal Trade Commission today announced it will delay the compliance date for the new Red Flag Rules until August 1, 2009.  This three-month extension is intended to give businesses covered by the rules more time to develop their identity theft detection programs.  To read the FTC's press release, click here.

American Medical Association Posts Red Flag Rules Compliance Resources - Including a Sample Policy
Apr., 2009: The American Medical Association has posted resources for physicians related to the Red Flag Rules issued by the Federal Trade Commission (FTC).  Physicians who are covered by the rule are required to comply by May 1, 2009.  The resources include a guidance document addressing some frequently asked questions as well as a sample Red Flag Rules policy document that physicians can customize to fit their individual practice.  To access the AMA Resources, click here.

Joint Commission Issues Sentinel Event Alert about Preventing Technology-Related Healthcare Errors
Dec. 11, 2008:  The Joint Commission today issued a Sentinel Event Alert about safely implementing Health Information Technology (HIT) systems.  The alert warns that using HIT does not guarantee success or patient safety, and urges greater attention to the process of selecting, implementing, and maintaining an HIT system.  To read the Alert, click here.

FDA Says Pharmacy-Provided Drug Information Not Consistently Clear or Useful
Dec. 16, 2008: The FDA today released the results of a study that found that Consumer Medication Information ("CMI") sheets provided by pharmacies to patients do not consistently provide clear, easy-to-read information about the risks and directions for use of medications. To read more about the study and CMI in general, click here.

FDA Announces It Will Require New Warnings On All Antiepileptic Drugs
Dec. 16, 2008: The FDA today announced that it has concluded a metastudy of suicidality associated with antiepileptic medications, and will require new warnings about an increased risk of suicidality on the labels of all such medications. In accordance with the recommendations made in July by their independent panel, FDA will not require black-box warnings. FDA recommends that all patients who are on antiepileptics for any indication "be monitored for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression." To learn more, visit FDA's webpage on antiepileptic medications by clicking here.

OCR and Department of Education Issue Joint Guidance on HIPAA and FERPA
Nov. 25, 2008:  In response to questions from schools and providers, as well as the "Report to the President on Issues Raised by the Virginia Tech Tragedy" (http://www.hhs.gov/vtreport.html), the Office for Civil Rights and the Department of Education today issued a joint guidance document regarding records created and information learned during treatment at a school facility, such as a Student Health Clinic or Student Counseling Center.  The guidance addresses when records are covered by FERPA, when they are covered by HIPAA, and when information may be disclosed in either case.  To read the guidance, click here.

Preliminary FDA Data Suggest Increased Risk of SJS and TEN for Asian Patients on Phenytoin or Fosphenytoin Sodium
November 24, 2008: The FDA today announced that it is investigating preliminary data about Phenytoin and Fosphenytoin Sodium that suggest an increased risk of serious skin reactions, including Stevens Johnson Syndrome and toxic epidermal necrolysis, in Asian patients who test positive for HLA-B* 1502. Until the investigation is completed, FDA recommends special attention to the risk/benefit profile discussed on the drug's label. For more information, click here.

Ethex Corp Recalls Generic Morphine Sulfate, Dextroamphetamine Sulfate, and Two Other Medications
November 10, 2008:  Ethex Corp and the FDA notified healthcare providers of a recall of Propafenone HCL tablets, Isosorbide Mononitrate ER tablets, Morphine Sulfate ER tablets, Morphine Sulfate IR tablets, and Dextroamphetamine Sulfate tablets.  These products may contain oversized tablets, and up to twice the expected dose of the active ingredient.  For more information, view the FDA MedWatch post here.

Recall of Dextroamphetamine Sulfate tablets
October 16, 2008:  Today, FDA and Ethex Corp announced a voluntary recall of three lots of Dextroamphetamine Sulfate 5mg tablets.  Some tablets in these lots may contain as much as twice the labeled amount of the active ingredient, increasing the risk of side-effects.  To read the MedWatch announcement, click here.

Industry Consortium Releases Guidelines for Preventing Hospital-Acquired Infections
October 8, 2008:  Today a consortium of industry associations including the Joint Commission, American Hospital Association, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, and Association for Professionals in Infection Control released guidelines for preventing hospital-acquired infections ("HAIs").  Although previous guidelines have provided evidence-based recommendations for detecting and preventing HAIs, these new guidelines include practical recommendations designed to assist hospitals in implementing and prioritizing HAI prevention efforts.  To download a copy of the guidelines and for more information, click here.

OCR Issues Guidance on HIPAA Privacy Rule, Talking to Patient's Family Members
September 16, 2008: Today the Office for Civil Rights, the agency responsible for enforcing HIPAA, issued guidance for both patients and providers about when a provider may - under the federal Privacy Rule - communicate with a patient's family, friends, and other persons involved in care. The guidance for providers explains how the rule operates in several scenarios, and gives examples of things providers can and cannot do in those scenarios. To download a copy of the guidance document, click hereIt is important to remember that this guidance only addresses the requirements of HIPAA. Your state's law, and your ethical obligations, may be more protective of patient information

HIPAA Enforcement By HHS
September 9, 2008: The two HHS agencies responsible for enforcement of HIPAA’s Privacy Rule and Security Rule have made detailed enforcement information available online. HHS’ Office for Civil Rights (OCR) has made Privacy Rule enforcement information available at http://www.hhs.gov/ocr/privacy/enforcement/ including the following:

  • Enforcement process
  • Enforcement statistics
  • Enforcement case examples

HHS’ Center for Medicare and Medicaid Services (CMS) has made Security Rule enforcement information available at http://www.cms.hhs.gov/Enforcement/ including the following:

  • Compliant examples
  • Compliance review information and examples
  • Enforcement statistics

FDA Now Posts Quarterly Listings of Medications Being Investigated for Potential Problems
Sept 5, 2008:  FDA today posted the first of what will be quarterly listings of medications being investigated for potential problems.  The listings indicate that potential signals of serious risks have been identified for the medication using the Adverse Event Reporting System data, but do not indicate that the FDA believes the drug actually has the risk.  Medications listed will be investigated further by the FDA to determine whether the signals identified correspond to any actual risk or not.  FDA is required to post this list by law, and states that "the listing of a drug and a potential safety issue on this Web site does not mean that FDA is suggesting prescribers should not prescribe the drug or that patients taking the drug should stop taking the medication."  Instead, the lists are intended to promote communication between patients and physicians about prescription drug safety. 
To view the list, click here.  To read FDA's explanation of the list, click here.

Information Available About Adverse Events Involving Methodone
Aug., 2008: Information about serious adverse events and deaths involving methadone prescribed for chronic pain is becoming more widely available.  Such events have been reported even when medication abuse is not present.  It is essential that physicians who prescribe methadone and other opioids for pain management understand the risks associated with these medications.  The US Substance Abuse and Mental Health Services Administration ("SAMHSA"), in conjunction with local medical boards, schools, hospitals and societies sponsors CME classes on prescribing opioids for pain management.  For more information about these ACCME-accredited courses, click here.

Guidelines Issued for Use of Medication Samples
June 24, 2008: The National Coordinating Council for Medication Error Reporting and Prevention today issued guidelines for dispensing medication samples, designed to highlight risks involved with the use of samples and to help prevent errors. The guidelines are available on NCCMERP's website. Click here to view the guidelines.

The American College of Obstetricians and Gynecologists (ACOG) has updated and reissued its Practice Bulletin No. 92: "Use of Psychiatric Medications During Pregnancy and Lactation." 
Members of ACOG can access the Practice Bulletin on the ACOG web site (www.acog.org) under "Publications," then "Practice Bulletins." The study was also published in Obstetrics & Gynecology (Apr, 2008; 111:1001-1020) and may be purchased from the journal web site at www.greenjournal.org.A summary of the information can be found at Medscape.

Preventing Pediatric Medication Errors
April 11, 2008: The Joint Commission has issued a Sentinel Event Alert which includes specific strategies for reducing pediatric medication errors. Click here to view the alert.

American Heart Association Issues Statement: "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs"
The American Heart Association and American Academy of Pediatrics have issued a joint statement clarifying recommendations about obtaining ECGs prior to pharmacological treatment of children and adolescents with ADHD. To resolve confusion regarding AHA's 4/21/08 statement entitled "Cardiovascular Monitoring of Children and Adolescents with Heart Disease Receiving Stimulant Drugs," the AAP and AHA released this joint statement clarifying the strength of various recommendations regarding obtaining a focused cardiac history and obtaining an ECG prior to initiating pharmacological therapies for ADHD. Obtaining the history is strongly recommended; obtaining the ECG is considered reasonable, but is not expected for all patients.

CDC’s MMWR Report Addresses School-Associated Student Homicides
View January 18, 2008 Report: http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5702a1.htm

CDC Reports A Rise In Unintentional Poisoning Deaths Involving Psychotherapeutic Drugs
"Unintentional drug poisoning mortality rates increased substantially in the United States during 1999--2004. Previous studies, using multiple cause-of-death data, have indicated that the trend described in this report can be attributed to. . . prescription psychotherapeutic drugs (e.g., sedatives), and cannot be attributed to heroin, methamphetamines, or other illegal drugs (3,5)." Read the entire article.

Final Rule - Multiple Prescriptions for Schedule II Drugs
11-7-07: The DEA has issued a final rule - "Issuance of Multiple Prescriptions for Schedule II Controlled Substances". The rule, codified at 21 CFR Part 1306, is effective December 19, 2007.
DEA regulations have been amended "to allow [under certain specified conditions] practitioners to provide individual patients with multiple prescriptions, to be filled sequentially, for the same schedule II controlled substance, with such multiple prescriptions having the combined effect of allowing a patient to receive over time up to a 90-day supply of that controlled substance".
Click here to read the rule. [NOTE: The actual modifications to the rule appear at the very end of the document.]

New ADHD Resource from APA / AACAP
ParentsMedGuide.org, the online resource center for patients, families, and physicians, has made a new ADHD resource available. Developed by the APA and AACAP, this new resource - The Medication Guide for Treating ADHD - is available for download at http://www.parentsmedguide.org/

HHS Issues Security Guidance on Use of Laptops and Other Portable Devices
CMS, the HHS agency responsible for enforcement of HIPAA's Security Rule, has issued a guidance document related to the security of laptops and other portable devices. The document provides specific strategies that CMS may consider reasonable and appropriate for offsite access to electronic protected health information (EPHI).

View guidance document.

Final Rule Issued on Restraints and Seclusion
12-8-06: The Centers for Medicare and Medicaid Services published a final rule on patients' rights for facilities participating in the Medicare and Medicaid programs. Among other things, the rule:

  • has stricter standards for restraint and seclusion training,
  • allows additional types of practitioners to conduct the required face-to-face evaluation within one hour of the use of restraint or seclusion,
  • and increases the obligation to report deaths associated with restraints or seclusion.

To view the rule, please click here.

HHS Releases Regulations Creating Exceptions to the Stark and Anti-Kickback Laws for Electronic Prescribing and Electronic Health Records Technology

SAMHSA Releases Roadmap to Seclusion and Restraint Free Mental Health Services
View Report.

Medicare Prescription Drug Benefit - Medicare Part D
View article.

JCAHO Announces 2007 National Patient Safety Goals for Behavioral Health Care Organizations
View Press Release.

JCAHO Announces 2006 National Patient Safety Goals for Behavioral Health Care Organizations
View Press Release.

FDA Issues Public Health Advisory for Adderall

Antidepressant Use

Speak Up Program

JCAHO's Speak Up Program to Prevent Medical Errors Develops Patient Brochure to Prevent Medication Mistakes
www.jcaho.org/news+room/press+kits/medication_mistakes/index1.htm

FDA Continuously Updates Its MEDWATCH – Medical Product Safety Information – Webpage With Safety Alerts and Advisories, Safety-Related Drug Labeling Changes, and More
View FDA’s MEDWATCH
www.fda.gov/medwatch/safety.htm

NIH Sponsors "Preventing Violence and Related Health-Risking Social Behaviors in Adolescents" Conference

View AHRQ's summary of the background report:
http://www.ahrq.gov/clinic/epcsums/adolvisum.htm

View NIH's State-of-the-Science Conference Statement:
http://consensus.nih.gov/ta/023/youthviolenceDRAFTstatement101504.pdf

CDC’s MMWR Report Addresses Suicide
View June 11, 2004 Report: http://www.cdc.gov/mmwr/weekcvol.html

JCAHO’s Joint Commission Resources Launches Patient Safety Web Page
View the information: http://jcrinc.co.mansellgroup.net/UM/T.asp?A2557.25634.800.1.46848

GlaxoSmithKline Releases Pediatric Clinical Trials Data
View the information: www.gsk.com/media/paroxetine.htm

HHS’ SAMHSA Provides Educational Document Discussing the Confidentiality of Alcohol and Drug Abuse Treatment Records Regulation (42 CFR Part 2) and HIPAA’s Privacy Rule
View Report: http://www.hipaa.samhsa.gov/Part2ComparisonClearedTOC.htm

HHS Provides Guidance on Financial Relationships and Interests in Research Involving Human Subjects

View May 12, 2004 Press Release
www.hhs.gov/news/press/2004pres/20040512.html
View the Guidance
http://ohrp.osophs.dhhs.gov/humansubjects/finreltn/finalguid.pdf

OIG Posts Special Alert To Physicians About Extra Charges For Medicare Patients
View the OIG Alert:www.oig.hhs.gov/fraud/docs/alertsandbulletins/
2004/FA033104AssignViolationI.pdf

Federal Trade Commission Issues Tips For Businesses To Keep Their Computer Systems Secure
View the information
www.ftc.gov/opa/2004/04/cybersecure.htm

SAMHSA Announces A New Technical Assistance Center Available To Aid In Treatment of Co-Occurring Substance Abuse And Mental Health Disorders
View the information
www.samhsa.gov/news/newsreleases/040108nr_cooc_ta.htm

APA Publishes Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors
The APA has published the Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors as a Supplement to the November 30, 2003 issue of The American Journal of Psychiatry.
You can also view the APA's Practice Guideline online by clicking here.

CMS Issues Interim Guidance on EMTALA Enforcement
The Centers for Medicare & Medicaid Services (CMS) on May 13, 2004 issued Revised Emergency Medical Treatment and Labor Act (EMTALA) Interpretive Guidelines. To access the guidance, visit www.cms.hhs.gov/medicaid/survey-cert/sc0434.pdf

To view our EMTALA article from the Fall 2003 issue of our newsletter: Rx for Risk.

JCAHO Issues Additional Prohibited Abbreviations
2004 National Patient Safety Goals - FAQs: View the information.

Agency for Healthcare Research and Quality launches online patient safety resource and journal - Web M&M.
Agency for Healthcare Research and Quality launches online patient safety resource and journal -- Web M&M. The site features:

  • Analysis of medical errors reported anonymously, including psychiatric cases
  • interactive CME
  • links to other patient safety and medical errors resources

http://www.webmm.ahrq.gov

Receive complimentary copies of our risk management tips. Click here.